Altimmune stock tumbles after MASH drug trial data
Altimmune stock tumbles after MASH drug trial data
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
Institutional stablecoin use triples: Why B2B payments are crypto's new frontier
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Altimmune stock tumbles after MASH drug trial data
Mexican airline Volaris' shares take off after merger plans with Viva Aerobus
Autozi stock soars after securing $90 million investment from CDIB
Bipartisan crypto legislation faces critical juncture as Senator Tim Scott navigates competing pressures from crypto industry's $140 million Fairshake PAC...
Lyft (LYFT) faces growing risk from the accelerating shift toward autonomous vehicles, which Wedbush
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.
Over the past decade, Nvidia's stock has rarely been so inexpensive relative to the broader chip sector.
The Sejm passed the same version of the Crypto-Asset Market Act previously rejected by President Nawrocki, escalating political tensions.
ProPhase Labs stock soars after announcing reverse merger with ABL
Morgan Stanley just upgraded these 2 Japanese AI stocks
Thursday's Insider Pulse: Silence in Trading as Year-End Approaches
Amazon and Hims & Hers look like good picks for 2026.